Background: In studies of mild cognitive impairment (MCI) in Parkinson disease (PD),
patients without dementia have reported variable prevalences and profiles of MCI, likely to …

Objective: To examine the incidence, progression, and reversion of mild cognitive
impairment in patients with Parkinson disease (PD-MCI) over 5 years. Methods: A …

Objective: We examined the development of Parkinson disease (PD)–mild cognitive
impairment (MCI) in patients with newly diagnosed PD over 5 years using recently proposed …

The aims of this project were to determine the risk factors for and clinical characteristics of
mild cognitive impairment (MCI) in Parkinson's disease (PD). We performed a retrospective …

While Parkinson's disease (PD) traditionally has been defined by its characteristic motor
hallmarks, non-motor features such as cognitive impairment and dementia are increasingly …

Objective: To report the rates and predictors of progression from normal cognition to either
mild cognitive impairment (MCI) or dementia using standardized neuropsychological …

Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive
performance, which is suggestive of Mild Cognitive Impairment (MCI), representing a …

Background: Cognitive impairment in Parkinson's disease (PD) includes a spectrum varying
from Mild Cognitive Impairment (PD-MCI) to PD Dementia (PDD). The main aim of the …

Importance Mild cognitive impairment (MCI) is common in Parkinson disease (PD), but the
prognostic value of MCI in early PD is unknown. Objective To examine the course of MCI …

Objective Inconsistent results exist regarding the cognitive profile in patients with
Parkinson's disease with mild cognitive impairment (PD-MCI). We aimed at providing data …